Michael Powell, Director at Ocera Therapeutics, Inc. (OCRX), bought 1,093,721 shares at $6.03 ($2.4M) on 2013-07-15, disclosed to the SEC on 2013-07-17.
Open-market purchase of $2.4M OCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 702,555 | $0 | 0.0% |
| 2 | $6.03 | 4,400 | $27K | 1.1% |
| 3 | $6.03 | 63,957 | $386K | 16.4% |
| 4 | $6.03 | 322,809 | $1.9M | 82.5% |
| Total | $2.16 avg | 1,093,721 | $2.4M | 100% |
| Filing → |
| OCRX | SELL | 2016-12-30 | $15K | — | Filing → |
| MIRN | BUY | 2015-10-06 | $6.0M | — | Filing → |
| AERI | SELL | 2014-07-11 | $24.2M | — | Filing → |